Margit Hemetsberger - Publications

Successful Use of Difelikefalin in Severe Chronic Kidney Disease-Associated Pruritus in a Patient With Complex Etiological Contributors: A Case Report.

Journal: Case reports in nephrology

Published: October 10, 2024

Evolocumab effectiveness in the real-world setting: Austrian data from the pan-European observational HEYMANS study.

Journal: Wiener klinische Wochenschrift

Published: March 01, 2023

Characteristics and outcomes of patients with psoriasis treated with apremilast in the real-world in Austria - results the APPRECIATE study.

Journal: Therapeutic advances in chronic disease

Published: September 16, 2022

Interpreting the Benefit and Risk Data in Between-Drug Comparisons: Illustration of the Challenges Using the Example of Mefenamic Acid versus Ibuprofen.

Journal: Pharmaceutics

Published: September 14, 2022

Lipid lowering therapy in primary and secondary prevention in Austria: are LDL-C goals achieved? : Results from the DA VINCI study.

Journal: Wiener klinische Wochenschrift

Published: July 05, 2021

Epidemiology and economic burden of fragility fractures in Austria.

Journal: Osteoporosis international : a journal established as result of cooperation between the European Foundation for Osteoporosis and the National Osteoporosis Foundation of the USA

Published: May 25, 2021

Sex-Related Differences in Drugs with Anti-Inflammatory Properties.

Journal: Journal of clinical medicine

Published: February 17, 2021

LDL-cholesterol and cardiovascular events: the lower the better?

Journal: Wiener medizinische Wochenschrift (1946)

Published: June 27, 2016

Management of secondary hyperparathyroidism: practice patterns and outcomes of cinacalcet treatment with or without active vitamin D in Austria and Switzerland - the observational TRANSIT Study.

Journal: Wiener klinische Wochenschrift

Published: October 02, 2015

Denosumab for the treatment of giant cell tumor of the bone.

Journal: Future oncology (London, England)

Published: July 11, 2015

EARLIER: an observational study to evaluate the use of cinacalcet in incident hemodialysis patients with secondary hyperparathyroidism in daily clinical practice.

Journal: Wiener medizinische Wochenschrift (1946)

Published: November 13, 2014

Darbepoetin alfa once every 2 weeks effectively maintained hemoglobin in dialysis patients in an observational study: Austrian cohort of ALTERNATE.

Journal: Wiener medizinische Wochenschrift (1946)

Published: August 20, 2013